FAP and cholangiocarcinoma: Here, we aimed to assess the accuracy of PET/CT with the novel cancer fibroblast–directed 68Ga-fibroblast activation protein (FAP) inhibitor (FAPI)-46 tracer for cholangiocarcinoma staging and management guidance.